← Back to headlines
UroGen Settles Patent Dispute with Teva Over Jelmyto
UroGen Pharma has reached a settlement with Teva Pharmaceuticals regarding a patent dispute concerning its drug Jelmyto.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
